Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the cultural adaptation part of the study (Aim 1):
- People who identify as Hispanic and/or Latino(a)
- People who can read and speak in English or Spanish
- People between 50 and 77 years old
- People who currently smoke or used to smoke
- People who have smoked the equivalent of at least one pack per day for 20 years, or a similar total amount over time
For the main randomised trial part of the study (Aims 2–3):
- People who identify as Hispanic or Latino(a)
- People who can read and speak in English or Spanish
- People between 50 and 77 years old
- People who currently smoke, or who stopped smoking within the last 15 years
- People who have smoked the equivalent of at least one pack per day for 20 years, or a similar total amount over time
- People who have a routine (non-emergency) appointment already scheduled at one of the study clinics
- People who have not been coughing up blood in the last two weeks
For the healthcare provider interviews:
- Practicing primary care clinicians, clinic directors, nursing directors, clinic administrators, or study navigators at a participating site
- People aged 18 or older who are fluent in English
For the online provider surveys:
- Practicing primary care providers at a participating site, or study navigators
- People aged 18 or older who are fluent in English
Who may not be able to join:
For the main randomised trial:
- People who do not speak English (confirm with trial site)
- People who do not identify as Hispanic or Latino(a)
- People who have a history of lung cancer
- People who have had a CT scan in the past 12 months
- People who have been coughing up blood in the last two weeks
- People whose overall health conditions make them a poor candidate for curative treatment, as assessed by their primary care doctor
- People who are not able to give informed consent
For the provider interviews and online surveys:
- People who are not able to give informed consent
- Women who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Evelyn Arana, DrPH, Rutgers Cancer Institute of NJ
Phone: 9086420861
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment rate; Participant Acceptability; Follow-up completion rate; Intervention Fidelity Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.